Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

Published Date: 18 Oct 2025

In recent research, treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in patients with newly diagnosed ...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

TULSA Is Effective in Long-Term Prostate Cancer Control.

2.

Five new papers highlight cancer inequities, challenges and opportunities in South Asia

3.

Combination of significant weight gain and late motherhood greatly increases risk of breast cancer, study finds

4.

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

5.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot